Home > Boards > Canadian > Cannabis > MediPharm Labs Corp. (MEDIF)

MEDIPHARM $LABS: 2019-2020 Shareholder Updates :

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
Dude1967 Member Profile
Followed By 3
Posts 1,136
Boards Moderated 5
Alias Born 10/19/18
160x600 placeholder
Dude1967   Saturday, 10/12/19 02:39:39 PM
Re: None
Post # of 3725 
MEDIPHARM $LABS: 2019-2020 Shareholder Updates :

- Q1/2019 - revenue of 22M

- Q2/2019 - revenue of 31.42M

- Q3/2019 - November 12, 2019
Pre market

- Capital Structure:

Fully diluted shares (as of May 10, 2019): 140M + ~potentially 15M from its latest bought deal.. So approximately ~155M

- Business model: wholesale(Private labelling + white labelling)/tolling

Sales/tolling agreements with - Supreme, Terrascend, Emerald Health, Indiva, JWCA, Cronos Group, Canopy Growth, & undisclosed licensed producer

More agreements to be announced

- Current capacity of 150,000kg - expected to complete expansion to 250,000kg by end of Q2/19 (hopefully to be announced soon this week)

- Cashed up

- has closed a credit agreement (the “Credit Facility”) with a top 5 Canadian Schedule 1 bank (the “Bank”) for an aggregate $38.7 million.

recently closed a $75M bought deal @$5.55 option to purchase additional shares up to $86M

Signed $20M in debt with schedule 1 Bank

Total cash $100M+

- Up list to TSX

- Global reach

Facility under construction in Australia (Expected to be completed in H2 2019) - 75,000 KG capacity expected for H2 2019 (November)


Facility in Australia will be the HUB to export extracts/finished products into Asia Pacific

Facility in Canada will be the HUB to export extracts/finished products into Europe

Awaiting EU GMP certification - expected H2 2019 ( in order to ship to the EU)

Recently completed its first export shipment into Australia to AusCann Group holdings (https://www.stockwatch.com/News/Item.aspx?bid=Z-C%3aLABS-2776284&symbol=LABS®ion=C) ;

- Building towards a pharmceutical company

Formed a Science Advisory Committee group;expert scientist, researchers, and medical professionals

Focused on Pharma-grade cannabis oil and concentrates

More information here: https://www.civilized.life/articles/how-medipharm-is-preparing-for-the-future-of-cannabis/ ;

- Slides:




Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist